PF-00217830

Generic Name: PF-00217830

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₆H_₃₀N_₄O_₂

CAS Number: 846032-02-8

Unique Ingredient Identifier: 8BC08N1MS5

Background: PF-00217830 has been used in trials studying the treatment of Schizophrenia.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia

Phase 2

Completed

Conditions: Schizophrenia

Interventions: Drug: Aripiprazole
Other: Placebo
Drug: PF-00217830

First Posted Date: 2007-12-24

Last Posted Date: 2012-04-18

Lead Sponsor: Pfizer

Target Recruit Count: 164

Registration Number: NCT00580125

Locations: 🇺🇦
Pfizer Investigational Site, Lugansk, Ukraine

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy